Trial to Determine MTD of BI 836845 Administered Intravenously Once Every Three Weeks in Patients With Advanced Solid Tumours and Later a Weekly Dosing Schedule in Selected Tumour Types
Clinical trial NCT01317420 · COMPLETED
Trial details
- NCT number
- NCT01317420
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-13
- Primary completion
- 2016-02-15
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.